1.Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
Yusuke UCHINAMI ; Koichi YASUDA ; Hideki MINATOGAWA ; Yasuhiro DEKURA ; Noboru NISHIKAWA ; Rumiko KINOSHITA ; Kentaro NISHIOKA ; Norio KATOH ; Takashi MORI ; Manami OTSUKA ; Naoki MIYAMOTO ; Ryusuke SUZUKI ; Keiji KOBASHI ; Yasushi SHIMIZU ; Jun TAGUCHI ; Nayuta TSUSHIMA ; Satoshi KANO ; Akihiro HOMMA ; Hidefumi AOYAMA
Radiation Oncology Journal 2024;42(1):74-82
Purpose:
To investigate the clinical significance of adaptive radiotherapy (ART) in locally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT).
Materials and Methods:
Eligible patients were treated with concurrent chemoradiotherapy using IMRT. Planning computed tomography in ART was performed during radiotherapy, and replanning was performed. Since ART was started in May 2011 (ART group), patients who were treated without ART up to April 2011 (non-ART group) were used as the historical control. The Kaplan-Meier method was used to calculate overall survival (OS), locoregional recurrence-free survival (LRFS), progression-free survival (PFS), and distant metastasis-free survival (DMFS). LRFS for the primary tumor (LRFS_P) and regional lymph node (LRFS_LN) were also studied for more detailed analysis. Statistical significance was evaluated using the log-rank test for survival.
Results:
The ART group tended to have higher radiation doses. The median follow-up period was 127 months (range, 10 to 211 months) in the non-ART group and 61.5 months (range, 5 to 129 months) in the ART group. Compared to the non-ART group, the ART group showed significantly higher 5-year PFS (53.8% vs. 81.3%, p = 0.015) and LRFS (61.2% vs. 85.3%, p = 0.024), but not OS (80.7% vs. 80.8%, p = 0.941) and DMFS (84.6% vs. 92.7%, p = 0.255). Five-year LRFS_P was higher in the ART group (61.3% vs. 90.6%, p = 0.005), but LRFS_LN did not show a significant difference (91.9% vs. 96.2%, p = 0.541).
Conclusion
Although there were differences in the patient backgrounds between the two groups, this study suggests the potential effectiveness of ART in improving locoregional control, especially in the primary tumor.
2.A Case of Malignant Gastrointestinal Obstruction in a Hyponutritional State That Was Treated with Staging Laparoscopy and Laparoscopic Jejunostomy to Enable Oral Intake
Koji OTSUKA ; Kazunari KATSURA ; Takahiro MITANI ; Daisuke NOZOE ; Kazuma TAGAMI ; Ayako MAEKAWA ; Noboru SUGAWARA ; Keiko KAGA ; Takuji HIRANO
Palliative Care Research 2023;18(2):153-158
Treatment for malignancy bowel obstruction (MBO) includes surgery, gastrointestinal stenting, nasogastric tube, percutaneous endoscopic gastrostomy, and drug therapy. Drug therapy such as octreotide acetate significantly reduces the quality of life of patients because oral intake is no longer possible and continuous intravenous infusion is required. After a multidisciplinary conference including the department of gastrointestinal surgery and the department of palliative medicine, we could perform staging laparoscopy on a nutritionally-depleted patient with MBO and laparoscopic jejunostomy as a palliative surgery. As a result, she could discontinue from administration of octreotide acetate and resume oral intake.
4.Clinical Results of Surgical Resection and Histopathological Evaluation of Synovial Chondromatosis in the Shoulder: A Retrospective Study and Literature Review
Daisuke UTASHIMA ; Noboru MATSUMURA ; Taku SUZUKI ; Takuji IWAMOTO ; Kiyohisa OGAWA
Clinics in Orthopedic Surgery 2020;12(1):68-75
BACKGROUND:
Synovial chondromatosis occurs rarely in the shoulder, and its details remain unclear. The purpose of this study was to clarify the clinical results of surgical resection and the histopathological findings of synovial chondromatosis in the shoulder.
METHODS:
Ten shoulders with synovial chondromatosis that had been operatively resected were reviewed retrospectively. Osteochondral lesions were present in the glenohumeral joint in six shoulders and in the subacromial space in four shoulders. Two patients had a history of trauma with glenohumeral dislocation without recurrent instability, and the other seven patients (eight shoulders) did not have any traumatic episodes or past illness involving the ipsilateral shoulder girdle. The occurrences of osteochondral lesions, inferior humeral osteophytes, and acromial spurs were assessed on radiographs before resection, just after resection, and at final follow-up. The Constant scores were compared before resection and at final follow-up with Wilcoxon signed-rank tests. Resected lesions were histopathologically differentiated between primary and secondary synovial chondromatosis.
RESULTS:
Inferior humeral osteophytes were found in five shoulders with synovial chondromatosis in the glenohumeral joint, and all four shoulders with synovial chondromatosis in the subacromial space had acromial spur formation. Osteochondral lesions appeared to have been successfully removed in all shoulders on postoperative radiographs. At the final follow-up, however, one shoulder with secondary synovial chondromatosis in the subacromial space showed recurrence of osteochondral lesions and acromial spur formation. The mean Constant score improved significantly from 53.0 points before resection to 76.0 points at a mean follow-up of 6.0 years (p = 0.002). On histopathological evaluation, one shoulder was diagnosed as having primary synovial chondromatosis, while nine shoulders had secondary synovial chondromatosis.
CONCLUSIONS
The present study showed that resection of shoulder osteochondral lesions successfully relieved the clinical symptoms and that primary synovial chondromatosis is less common than secondary synovial chondromatosis in the shoulder. Although most of the present osteochondral lesions were clinically determined to be primary chondromatosis, only one case was histopathologically categorized as primary synovial chondromatosis. These results suggest that histopathological identification is needed to differentiate between primary and secondary synovial chondromatosis.
5.Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.
Mahmood A HAMED ; Seiichi NAKATA ; Kazuya SHIOGAMA ; Kenji SUZUKI ; Ramadan H SAYED ; Yoichi NISHIMURA ; Noboru IWATA ; Kouhei SAKURAI ; Badawy S BADAWY ; Ken-ichi INADA ; Hayato TSUGE ; Yutaka TSUTSUMI
Clinical and Experimental Otorhinolaryngology 2017;10(3):213-220
OBJECTIVES: Cholesteatoma is a nonneoplastic destructive lesion of the temporal bone with debated pathogenesis and bone resorptive mechanism. Both molecular and cellular events chiefly master its activity. Continued research is necessary to clarify factors related to its aggressiveness. We aimed to investigate the expression of Ki-67, cytokeratin 13 (CK13) and cytokeratin 17 (CK17) in acquired nonrecurrent human cholesteatoma and correlate them with its bone destructive capacity. METHODS: A prospective quantitative immunohistochemical study was carried out using fresh acquired cholesteatoma tissues (n=19), collected during cholesteatoma surgery. Deep meatal skin tissues from the same patients were used as control (n=8). Cholesteatoma patients were divided into 2 groups and compared (invasive and noninvasive) according to a grading score for bone resorption based upon clinical, radiologic and intraoperative findings. To our knowledge, the role of CK17 in cholesteatoma aggressiveness was first investigated in this paper. RESULTS: Both Ki-67 and CK17 were significantly overexpressed in cholesteatoma than control tissues (P < 0.001 for both Ki-67 and CK17). In addition, Ki-67 and CK17 were significantly higher in the invasive group than noninvasive group of cholesteatoma (P=0.029, P=0.033, respectively). Furthermore, Ki-67 and CK17 showed a moderate positive correlation with bone erosion scores (r=0.547, P=0.015 and r=0.588, P=0.008, respectively). In terms of CK13, no significant difference was found between cholesteatoma and skin (P=0.766). CONCLUSION: Both Ki-67 and CK17 were overexpressed in cholesteatoma tissue and positively correlated with bone resorption activity. The concept that Ki-67 can be a predictor for aggressiveness of cholesteatoma was supported. In addition, this is the first study demonstrating CK17 as a favoring marker in the aggressiveness of acquired cholesteatoma.
Bone Resorption
;
Cholesteatoma*
;
Ear, Middle
;
Humans*
;
Keratin-13*
;
Keratin-17*
;
Keratins*
;
Ki-67 Antigen
;
Prospective Studies
;
Skin
;
Temporal Bone
6.Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.
Mahmood A HAMED ; Seiichi NAKATA ; Ramadan H SAYED ; Hiromi UEDA ; Badawy S BADAWY ; Yoichi NISHIMURA ; Takuro KOJIMA ; Noboru IWATA ; Ahmed R AHMED ; Khalid DAHY ; Naoki KONDO ; Kenji SUZUKI
Clinical and Experimental Otorhinolaryngology 2016;9(4):298-308
Cholesteatoma is a cystic non tumorous lesion of the temporal bone that has the ability to destroy nearby structures by its power to cause bone resorption and as a result, fatal complications prevail. We aimed to conduct a comprehensive review for pathogenesis of acquired cholesteatoma, bone resorption mechanisms, and offer a future vision of this serious disease. We have reviewed different theories for pathogenesis of acquired cholesteatoma including the most relevant and updated ones with special emphasis on the mechanisms of bone resorption through Medline/PubMed research using the keywords ‘aetiopathogenesis, bone resorption, acquired cholesteatoma, temporal bone, and cytokines.’ In order to strengthen our study, we searched the reference lists of identified reviews. Cholesteatoma is a subject of debate among otolaryngologists since it was prescribed firstly. Over many decades, several theories were postulated for aetiopathogenesis of cholesteatoma with a tendency to follow more than one theory to explain the proper nature of that disease. Until now, the mechanism of bone resorption has yet to be more clarified. In the last century, a leap has occurred in the field of biomolecular cholesteatoma research which improved our knowledge about its pathophysiology and bone destructive mechanism. However, surgery is still the only available treatment. We conclude that discovery of new therapeutic choices for cholesteatoma other than surgery by the use of anti-growth, anti-proliferative, apoptotic agents as well as medications that antagonize osteoclastogenesis should be the main concern in the future clinical and experimental research work. Also, searching for predictors of the aggressiveness of cholesteatoma can affect the timing of intervention and prevent occurrence of complications.
Bone Resorption*
;
Cholesteatoma*
;
Cytokines
;
Temporal Bone
7.Possible association between recent migration and hospitalisation for dengue in an urban population: A prospective case-control study in northern Vietnam
Ataru Tsuzuki ; Vu Trong Duoc ; Toshihiko Sunahara ; Motoi Suzuki ; Nguyen Hoang Le ; Yukiko Higa ; Lay-Myint Yoshida ; Futoshi Hasebe ; Tran Vu Phong ; Noboru Minakawa
Tropical Biomedicine 2014;31(4):698-708
A prospective case–control study was conducted in urban districts in Hanoi,
northern Vietnam to evaluate the effect of migration on the risk of hospitalisation for dengue
in a Vietnamese urban population. We enrolled laboratory-confirmed dengue patients aged
>18 years who were hospitalised in local hospitals in November and December 2010. Four
neighbourhood-matched controls for each case were recruited within a week of hospitalisation.
Sociodemographic data were collected by interviews, and the number of immature and adult
mosquitoes within household premises was counted by entomological survey. Matched-pair
analyses were conducted using conditional logistic regression models. Among 43 cases and
168 controls, 84% and 83% were migrants from rural areas, respectively. Although statistical
significance was marginal, recent migration (residing in study area for <5 years) independently
increased the risk of hospitalisation for dengue compared with inhabitants after controlling
for potential confounders (adjusted odds ratio [aOR] = 3.78; 95% confidence interval [CI] =
0.99–14.27), whereas longer-term migration (residing in study area for >6 years) did not
change the risk (aOR = 1.1; 95% CI = 0.30–4.05). Younger age (18–34 years) (aOR = 7.26; 95%
CI = 2.39–22.06) and higher adult Aedes aegypti infestation level within household premises
(aOR = 9.25; 95% CI = 1.68–51.09) were also independently associated with hospitalisation
for dengue. Recent migration from rural areas seems to increase the risk of hospitalisation for
dengue in urban populations in endemic areas. Further research including cohort study should
be done to confirm the impact of migration on the risk of dengue in urban areas.
8.EFFECT OF ACUTE RESISTANCE EXERCISE ON BONE METABOLISM DURING MENSTRUAL CYCLE
NATSUMI SUZUKI ; KATSUJI AIZAWA ; AKIKO MEKARU ; MI HYUN JOO ; FUMIE MURAI ; NAOKI MUKAI ; NOBORU MESAKI
Japanese Journal of Physical Fitness and Sports Medicine 2007;56(2):215-222
[Objective] The aim of this investigation was to evaluate bone metabolism responses to acute resistance exercise during the menstrual cycle. [Methods] Subjects were young healthy sedentary women (n=7) with regular menstrual cycles. The subjects performed acute resistance exercise in each phase (follicular and luteal) of the menstrual cycle. Bone metabolism markers (bone formation marker BAP and bone resorption marker ICTP), bone metabolism related hormones (parathyroid hormone, calcitonin, calcium and inorganic phosphorus) and lactate were determined. Blood samples were collected before (Pre) and immediately following the exercise (Post), 1 hour (P1h) and 24 hours (P24h) after the exercise. [Results] BAP significantly increased at Post compared with Pre both in the follicular and luteal phases (p<0.05), but significantly decreased at P1h and P24h in the luteal phase. ICTP significantly increased at Post in the follicular phase (p<0.05) and significantly decreased at P1h and P24h in the luteal phase. The bone metabolism responses in the luteal phase moved to low-bone turnover at P1h and P24h. [Conclusion] The bone metabolism response to acute resistance exercise was different between menstrual phases. These results suggest that bone metabolism is influenced by the menstrual cycle.
9.EFFECT OF ACUTE EXERCISE ON HEMOLYSIS AND OXIDATIVE STRESS IN FEMALE ATHLETES
MITSUMI SUZUKI ; MI HYUN JOO ; NATSUMI SUZUKI ; NOBORU MESAKI
Japanese Journal of Physical Fitness and Sports Medicine 2006;55(2):259-268
Background : The incidence of anemia in the female athlete is high, and anemia causes not only a decrease in performance, but also various subjective symptoms. It is said that the cause of hemolysis -a type of anemia- is a decrease in antioxidants and an increase in the reactive oxygen species caused by exercise. Purpose : This study investigated the effect of acute exercise on hemolysis and oxidative stress in female athletes. Methods : On the basis of basal body temperature (BBT) data and urinary ovulation tests of the subjects (age 20.5±1.0 yr ), they were divided into two groups : eumenorrheic athletes (Eu, n=12) group, and irregular menstrual athletes (Am, n=9). The subjects performed an acute period of exhausting exercise on a bicycle ergometer. Lactate, hemoglobin, hematocrit, RBC, serum estradiol, haptoglobin, thiobarbituric acid reactive substances (TBARS) were determined in blood samples collected at rest and after exercise. Results : Lactate increased and hemoglobin, hematocrit, RBC, haptoglobin decreased after exercise in both the Eu and Am groups (p<0.05). However, serum TBARS did not show a significant change after exercise in both the Eu and Am groups. Conclusion : These results suggest that hemolysis may have developed, because haptoglobin decreased as a result of acute exercise. However, it is thought that the effect of oxidative stress is small because TBARS were not changed by acute exercise in both Eu and Am groups. In addition, there was no significant correlation between hemolysis and estrogen.
10.Usefulness of electronic medical record system for clinical clerkship
Mikihiro TSUTSUMI ; Ariyuki HORI ; Naohiro KURODA ; Koji SUZUKI ; Noboru TAKEKOSHI
Medical Education 2003;34(6):399-402
We compared the effects on clinical clerkships of an electronic medical record (EMR) system and a standard medical record system. Using an EMR system, students described medical records with a problem-oriented medical record system/subject objective assessment, and plan that was much better than the standard medical record system. In the EMR system, students cannot see physicians' medical records, including laboratory data and X-ray films. Instead, students themselves must obtain the patient history and request examinations as physicians do. This system helps supervisors give suitable comments and provide data that students have requested. Directors can also evaluate supervisors by reviewing their comments. Therefore, an EMR system has the advantage of problem-oriented medical record system-based learning for students and is also useful for clinical clerkships.


Result Analysis
Print
Save
E-mail